ATP1B3 and neoplasm: Using a novel flow cytometry technique for detecting disseminated tumor cells in models of low tumor burden using the human cell marker CD298 [35], we analyzed plasma for the presence of CTCs and bone marrow for the presence of disseminated tumor cells (DTCs) (gating scheme can be found in Supplemental Figure S2).